Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natesto in Male Hypogonadism
NCT01446042Phase 3Completed
- Sponsor
- Acerus Pharmaceuticals
- Start
- Sep 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of natesto in Hypogonadism, sponsored by Acerus Pharmaceuticals. Started Sep 2011; status: completed.
02
Drugs
natesto
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01446042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01446042.